Ryan K - Search Results

1

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.

Samples L, Voutsinas J, Fakhri B, Khajavian S, Spurgeon S, Stephens D, Skarbnik A, Mato A, Broome C, Gopal A, Smith S, Lynch R, Rainey M, Kim MS, Barrett-Campbell O, Hemond E, Tsang M, Ermann D, Malakhov N, Rao D, Shakib-Azar M, Morrigan B, Chauhan A, Plate T, Gooley T, Ryan K, Lansigan F, Hill B, Pongas G, Parikh SA, Roeker L, Allan JN, Cheng R, Ujjani C, Shadman M. Samples L, et al. Among authors: ryan k. Blood Adv. 2024 May 14;8(9):2085-2093. doi: 10.1182/bloodadvances.2023011569. Blood Adv. 2024. PMID: 38315043 Free PMC article.

2

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.

Roeker LE, DerSarkissian M, Ryan K, Chen Y, Duh MS, Wahlstrom SK, Hakre S, Yu L, Guo H, Mato AR. Roeker LE, et al. Among authors: ryan k. Blood Adv. 2023 Aug 22;7(16):4291-4301. doi: 10.1182/bloodadvances.2023009739. Blood Adv. 2023. PMID: 37163361 Free PMC article.

3

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

Barrientos JC, Ayed AO, Cha A, Du S, Fang B, Hall R, Marks SM, Peng E, Rhodes JM, Ryan K, Winters SB, Yeung PL, Hou JZ. Barrientos JC, et al. Among authors: ryan k. Target Oncol. 2023 Sep;18(5):727-734. doi: 10.1007/s11523-023-00988-0. Epub 2023 Sep 20. Target Oncol. 2023. PMID: 37728835 Free PMC article.

4

Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.

Engel-Nitz NM, Johnson MP, Bunner SH, Ryan KJ. Engel-Nitz NM, et al. J Manag Care Spec Pharm. 2020 Jun;26(6):729-740. doi: 10.18553/jmcp.2020.26.6.729. J Manag Care Spec Pharm. 2020. PMID: 32463768 Free PMC article.

5

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.

Hansen RN, Zhang Y, Seal B, Ryan K, Yong C, Darilay A, Ramsey SD. Hansen RN, et al. Among authors: ryan k. BMC Cancer. 2020 Apr 5;20(1):276. doi: 10.1186/s12885-020-06734-3. BMC Cancer. 2020. PMID: 32248816 Free PMC article.

6

Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer.

Bobbili P, Ryan K, Duh MS, Dua A, Fernandes AW, Pavilack M, Gomez JE. Bobbili P, et al. Among authors: ryan k. Future Oncol. 2019 Oct;15(29):3381-3393. doi: 10.2217/fon-2019-0282. Epub 2019 Sep 23. Future Oncol. 2019. PMID: 31544510

7

Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer.

Bobbili P, Ryan K, DerSarkissian M, Dua A, Yee C, Duh MS, Gomez JE. Bobbili P, et al. Among authors: ryan k. PLoS One. 2020 Mar 18;15(3):e0230444. doi: 10.1371/journal.pone.0230444. eCollection 2020. PLoS One. 2020. PMID: 32187231 Free PMC article.

8

Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs.

Lucero KT, Obodozie-Ofoegbu OO, Nooruddin Z, Ryan K, Castillo A, Moore AM, Jones X, Frei CR. Lucero KT, et al. Among authors: ryan k. J Manag Care Spec Pharm. 2023 Apr;29(4):420-430. doi: 10.18553/jmcp.2023.29.4.420. J Manag Care Spec Pharm. 2023. PMID: 36989449 Free PMC article.

9

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.

Frei CR, Le H, McHugh D, Ryan K, Jones X, Galley S, Franklin K, Baus CJ, Tavera J, Janania-Martinez M, Gregorio D, Ananth S, Uribe R, Surapaneni P, Espinoza-Gutarra M, Song MM, Teng C, Obodozie-Ofoegbu OO, Nooruddin Z. Frei CR, et al. Among authors: ryan k. Leuk Lymphoma. 2021 Jul;62(7):1664-1673. doi: 10.1080/10428194.2021.1876863. Epub 2021 Feb 11. Leuk Lymphoma. 2021. PMID: 33569992

10

Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.

Hou JZ, Ryan K, Du S, Fang B, Marks S, Page R, Peng E, Szymanski K, Winters S, Le H. Hou JZ, et al. Among authors: ryan k. Future Oncol. 2021 Dec;17(35):4959-4969. doi: 10.2217/fon-2021-0964. Epub 2021 Nov 16. Future Oncol. 2021. PMID: 34783255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,569 results

Search Page